Pages that link to "Q37086429"
Jump to navigation
Jump to search
The following pages link to Environmental factors as disease accelerators during chronic hepatitis C. (Q37086429):
Displaying 28 items.
- Smoking and the outcome of infection (Q27687123) (← links)
- Eligibility of persons who inject drugs for treatment of hepatitis C virus infection (Q30429470) (← links)
- Multiple variants in toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infection (Q33904205) (← links)
- Molecular mechanisms involved in the interaction effects of alcohol and hepatitis C virus in liver cirrhosis. (Q33959178) (← links)
- The association of toll-like receptor 4 polymorphism with hepatitis C virus infection in Saudi Arabian patients. (Q34081261) (← links)
- Marijuana use in hepatitis C infection does not affect liver biopsy histology or treatment outcomes (Q34088634) (← links)
- Age and ethnicity in cirrhosis (Q34231825) (← links)
- Endocannabinoid signaling at the periphery: 50 years after THC. (Q35572176) (← links)
- A novel approach to identify candidate prognostic factors for hepatitis C treatment response integrating clinical and viral genetic data. (Q35579175) (← links)
- Metabolic disorders and steatosis in patients with chronic hepatitis C: metabolic strategies for antiviral treatments (Q36026554) (← links)
- Morbidity and Mortality Among Community-Based People Who Inject Drugs With a High Hepatitis C and Human Immunodeficiency Virus Burden in Chennai, India (Q37089469) (← links)
- Clinical-guide risk prediction of hepatocellular carcinoma development in chronic hepatitis C patients after interferon-based therapy. (Q37279232) (← links)
- The impact of lifetime drug use on hepatitis C treatment outcomes in insured members of an integrated health care plan (Q37463091) (← links)
- Liver fibrosis: from animal models to mapping of human risk variants (Q37801093) (← links)
- Lack of an association between -308G>A polymorphism of the TNF-α gene and liver cirrhosis risk based on a meta-analysis (Q37957775) (← links)
- Healthcare contact and treatment uptake following hepatitis C virus screening and counseling among rural Appalachian people who use drugs (Q38710078) (← links)
- Effect of smoking on survival of patients with hepatocellular carcinoma (Q38806977) (← links)
- The association of non-O blood group and severity of liver fibrosis in patients with chronic hepatitis C infection (Q40037618) (← links)
- Impact of common risk factors of fibrosis progression in chronic hepatitis C. (Q41741892) (← links)
- Recommendations for the management of hepatitis C virus infection among people who inject drugs. (Q42280296) (← links)
- Protective effect of HLA-DRB1 11 and predisposition of HLA-C 04 in the development of severe liver damage in Brazilian patients with chronic hepatitis C virus infection (Q45356172) (← links)
- A 7-gene signature of the recipient predicts the progression of fibrosis after liver transplantation for hepatitis C virus infection (Q45361290) (← links)
- Hepatitis C virus infection in primary care: survey of registered nurses' knowledge and access to information. (Q45371534) (← links)
- Personality, Coping, and Well-Being for People Living with Chronic Hepatitis C. (Q48028755) (← links)
- Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts (Q50533517) (← links)
- Significance of *28 Genotype in Patients with Advanced Liver Injury Caused By Chronic Hepatitis C (Q64080407) (← links)
- Prediction of fibrosis progression in hepatitis C infection: Are genetics ready for clinical use? (Q83445215) (← links)
- Cannabis use disorders may protect against certain disorders of the digestive organs in people with schizophrenia but not in healthy controls (Q92424366) (← links)